一塩基多型 (SNP) 遺伝子型判定 技術と世界市場

Report Highlights

The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.

Report Ovewview

Summary:

Single nucleotide polymorphism (SNP) genotyping is a form of genotyping used to measure genetic variation. SNP, the most widely used form of genotyping, increases our understanding of the correlations between genotype and behavior exhibited by a living organism. SNP genotyping is generally used as a tool for identifying genomic variations and can lead to the determination of the health and ancestry of animals and plants. Increasing applications of SNPs in many areas is driving the market. However, diagnostics and pharmacogenomics represent the most attractive application areas for SNP genotyping. For SNP genotyping, several commercial platforms and methods have been developed.

SNPs cause phenotypic variations, influence the onset and course of many illnesses, and control how a gene reacts to medication and environmental stress. SNPs can also be molecular markers for determining the genes linked to significant biological traits and illnesses. Therefore, SNP profiling is important for pharmacological treatment, personalized medicine, agricultural productivity, and selective breeding. Alteration of a single nucleotide (A, T, C or G) in the genome sequence creates variations in the DNA sequence. A person’s unique DNA pattern combines several SNPs. The ability to grasp and treat human sickness is advanced by SNPs, the most general genome mutations among all living things. SNP genotyping is the most prominent segment of the market and is inherent to genomics.

Report Scope:

This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes:

– 37 data tables and 44 additional tables
– An overview of the global market for single nucleotide polymorphism (SNP) genotyping
– Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
– Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
– Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom’s MassArray DNA analysis platform, Bruker’s MALDI-TOF array, SNP pyrosequencing, microarrays and gene chips, and Applied Biosystems’ (now part of Thermo Fisher Scientific) SNPlex and TaqMan
– Analysis of the regulatory framework and policies affecting the industry
– Discussion of the ESG practices of, as well as challenges for, companies
– Analysis of the key companies’ market shares and their proprietary technologies, strategic alliances and patents
– Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

SNP for Mutational Analysis

SNP Definition

Methods of Studying SNPs

Classification of SNPs

PESTEL Analysis

Political

Economic

Social

Technological

Environmental

Legal

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Declining Prices of DNA Sequencing Methods

Demand for Personalized Treatments

Personalized Medicine and SNP Genotyping in the Drug Development Process

Increasing Demand for Genome Analysis in Plants and Animal Livestock

Market Restraints

Reimbursement Policies

Market Opportunities

Increasing Applications of SNP Genotyping

Rising Investments in Genomics Research

Chapter 4 Emerging Technologies and Developments

SNP-Chip

SNP Genotyping Technologies in Forensic Science

Artificial Intelligence in SNP Genotyping

Chapter 5 Market Segmentation Analysis

Market Trends

Segmentation Breakdown

Global Market for SNP Genotyping, by Technology

Microarrays and GeneChips

SNP Pyrosequencing

TaqMan Allelic Discrimination

Applied Biosystems SNPlex Platform

MassArray Maldi-TOF

Other SNP Genotyping Technologies

Global Market for SNP Genotyping, by Application

Pharmaceuticals and Pharmacogenomics

Diagnostic Research

Agricultural Biotechnology

Animal Genetics

Plant Improvements

Aquaculture

Other Applications

Geographic Breakdown

Global Market for SNP Genotyping, by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 6 Competitive Intelligence

Funding

Leading Companies

Key Strategies Adopted by Players

Partnerships

Other Strategies

Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective

ESG Performance in the Market

ESG Practices in the SNP Genotyping Industry

Environmental Performance

Social Performance

Governance Performance

ESG Risk Ratings

Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology

Acronyms

References

Company Profiles

AGILENT TECHNOLOGIES INC.

BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)

BIO-RAD LABORATORIES INC.

CYTIVA

ENZO BIOCHEM INC.

EPIGENDX

1. HOFFMANN-LA ROCHE LTD.

ILLUMINA INC.

QIAGEN

STANDARD BIOTOOLS

THERMO FISHER SCIENTIFIC INC.

List Of Tables

List of Tables

Summary Table : Global Market for SNP Genotyping, by Region, Through 2029

Table 1 : SNP Public Databases

Table 2 : Role of SNP Genotyping in Stages of the Drug Development Process

Table 3 : Global Market for SNP Genotyping, by Technology, Through 2029

Table 4 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, Through 2029

Table 5 : Global Market for Pyrosequencing in SNP Genotyping, by Region, Through 2029

Table 6 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, Through 2029

Table 7 : Global Market for Applied Biosystems SNPlex Platform in SNP Genotyping, by Region, Through 2029

Table 8 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, Through 2029

Table 9 : Global Market for Other Technologies in SNP Genotyping, by Region, Through 2029

Table 10 : Global Market for SNP Genotyping, by Application, Through 2029

Table 11 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, Through 2029

Table 12 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, Through 2029

Table 13 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, Through 2029

Table 14 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, Through 2029

Table 15 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, Through 2029

Table 16 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, Through 2029

Table 17 : Global Market for Other Applications in SNP Genotyping, by Region, Through 2029

Table 18 : Global Market for SNP Genotyping, by Region, Through 2029

Table 19 : North American Market for SNP Genotyping, by Technology, Through 2029

Table 20 : North American Market for SNP Genotyping, by Application, Through 2029

Table 21 : National Genome Projects in Europe

Table 22 : European Market for SNP Genotyping, by Technology, Through 2029

Table 23 : European Market for SNP Genotyping, by Application, Through 2029

Table 24 : Asia-Pacific Market for SNP Genotyping, by Technology, Through 2029

Table 25 : Asia-Pacific Market for SNP Genotyping, by Application, Through 2029

Table 26 : RoW Market for SNP Genotyping, by Technology, Through 2029

Table 27 : RoW Market for SNP Genotyping, by Application, Through 2029

Table 28 : Major Private and Public Funding Organizations

Table 29 : National Human Genome Research Institute, NIH Funded and Completed Projects

Table 30 : Leaders in the SNP Genotyping Market, 2023

Table 31 : Business Expansions in the Global SNP Genotyping Market, 2021–2024

Table 32 : Product Launches in the Global SNP Genotyping Market, 2021–2024

Table 33 : Collaborations and Agreements in the Global SNP Genotyping Market, 2022 and 2023

Table 34 : Partnerships in the Global SNP Genotyping Market, 2021–2024

Table 35 : Other Business Strategies Adopted by Key Players in SNP Genotyping Market, 2021–2024

Table 36 : Key Focus Areas in ESG Metrics

Table 37 : Environmental Performance Initiatives in the SNP Genotyping Market

Table 38 : Social Performance Initiatives in the SNP Genotyping Market

Table 39 : Governance Performance Initiatives in the SNP Genotyping Market

Table 40 : ESG Rankings for SNP Genotyping Companies, 2023*

Table 41 : Abbreviations Used in This Report

Table 42 : Agilent Technologies Inc.: Company Snapshot

Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023

Table 44 : Agilent Technologies Inc.: Product Portfolio

Table 45 : Agilent Technologies Inc.: News/Key Developments, 2021-2023

Table 46 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot

Table 47 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio

Table 48 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2021-2023

Table 49 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 50 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 51 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 52 : Cytiva: Company Snapshot

Table 53 : Cytiva: Product Portfolio

Table 54 : Cytiva: News/Key Developments, 2023

Table 55 : Enzo Biochem Inc.: Company Snapshot

Table 56 : Enzo Biochem Inc.: Financial Performance, FY 2022 and 2023

Table 57 : Enzo Biochem Inc.: Product Portfolio

Table 58 : Enzo Biochem Inc.: News/Key Developments, 2022

Table 59 : EpigenDx.: Company Snapshot

Table 60 : EpigenDx: Service Portfolio

Table 61 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 62 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 63 : F. Hoffman-La Roche Ltd.: Product Portfolio

Table 64 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021

Table 65 : Illumina Inc.: Company Snapshot

Table 66 : Illumina Inc.: Financial Performance, FY 2022 and 2023

Table 67 : Illumina Inc.: Services Portfolio

Table 68 : Illumina Inc.: News/Key Developments, 2022 and 2023

Table 69 : Qiagen: Company Snapshot

Table 70 : Qiagen: Financial Performance, FY 2022 and 2023

Table 71 : Qiagen: Product Portfolio

Table 72 : Qiagen: News/Key Developments, 2023 and 2024

Table 73 : Standard BioTools: Company Snapshot

Table 74 : Standard BioTools: Financial Performance, FY 2022 and 2023

Table 75 : Standard BioTools: Product Portfolio

Table 76 : Standard BioTools: News/Key Developments, 2022 and 2023

Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 80 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List Of Figures

List of Figures

Summary Figure : Global Market for SNP Genotyping, by Region, 2021–2029

Figure 1 : Classification of SNPs

Figure 2 : PESTEL Analysis: SNP Genotyping Market

Figure 3 : Market Dynamics of SNP Genotyping

Figure 4 : Average Cost Per Genome: Y-o-Y Trend, 2011–2022

Figure 5 : Snapshot of SNP Genotyping Market: Business Strategies

Figure 6 : Global Market Share for SNP Genotyping, by Technology, 2024

Figure 7 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, 2021–2029

Figure 8 : Global Market for Pyrosequencing in SNP Genotyping, by Region, 2021–2029

Figure 9 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, 2021–2029

Figure 10 : Global Market for Applied Biosystems SNPlex in SNP Genotyping, by Region, 2021–2029

Figure 11 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, 2021–2029

Figure 12 : Global Market for Other Technologies in SNP Genotyping, by Region, 2021–2029

Figure 13 : Global Market Share for SNP Genotyping, by Application, 2024

Figure 14 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, 2021–2029

Figure 15 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, 2021–2029

Figure 16 : Major Applications of SNP Genotyping in Agricultural Biotechnology

Figure 17 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, 2021–2029

Figure 18 : Applications of SNP Genotyping in Animal Genetics

Figure 19 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, 2021–2029

Figure 20 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, 2021–2029

Figure 21 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, 2021–2029

Figure 22 : Global Market for Other Applications in SNP Genotyping, by Region, 2021–2029

Figure 23 : Global Market Share for SNP Genotyping, by Region, 2024

Figure 24 : Share of New Genetic Tests in the U.S., by CLIA-certified Laboratory, 2012 to 2022

Figure 25 : North American Market for SNP Genotyping, by Technology, 2021–2029

Figure 26 : North American Market for SNP Genotyping, by Application, 2021–2029

Figure 27 : European Market for SNP Genotyping, by Technology, 2021–2029

Figure 28 : European Market for SNP Genotyping, by Application, 2021–2029

Figure 29 : Drivers of the Asia-Pacific Market for SNP Genotyping

Figure 30 : Asia-Pacific Market for SNP Genotyping, by Technology, 2021–2029

Figure 31 : Asia-Pacific Market for SNP Genotyping, by Application, 2021–2029

Figure 32 : RoW Market for SNP Genotyping, by Technology, 2021–2029

Figure 33 : RoW Market for SNP Genotyping, by Application, 2021–2029

Figure 34 : Share of the Global SNP Genotyping Market, Competitive Intelligence, by Strategy, 2021–2024

Figure 35 : How a Strong ESG Proposition Benefits Businesses

Figure 36 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023

Figure 37 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023

Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023

Figure 39 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023

Figure 40 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023

Figure 41 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 42 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023

Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023

Figure 45 : Qiagen: Revenue Share, by Business Unit, FY 2023

Figure 46 : Qiagen: Revenue Share, by Country/Region, FY 2023

Figure 47 : Standard BioTools: Revenue Share, by Business Unit, FY 2023

Figure 48 : Standard BioTools: Revenue Share, by Country/Region, FY 2023

Figure 49 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023

Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧